Mitochondria-targeting peptide (elamipretide) for cellular energy, heart health, cognitive resilience and oxidative stress protection.

Product Overview

SS31 (elamipretide) localises to the inner mitochondrial membrane and binds to cardiolipin to stabilise mitochondrial structure, support ATP production, reduce oxidative stress and protect against mitochondrial dysfunction. High-energy tissues: heart, skeletal muscle, nervous system. Biological half-life 2-4 hours.

Composition

SS31 (Elamipretide) 100mg

Strength & Volume

100mg | 2mL

Dosing System

200-click pen system

Per Click/Unit

0.5mg per unit

Beginner Dose

10 units (5mg) daily

Standard Dose

20 units (10mg) 2-3x/week

Max Dose

40 units (20mg) 2-3x/week

Frequency

Daily (low) or 2-3x per week (intermediate/high)

Cycle Length & Off Period

6-12 weeks | Off Period: 4 weeks

Key Benefits

Expected Outcomes

Mitochondrial efficiency / cellular energy handling / cardiac tissue support / brain and cognitive resilience / oxidative stress protection / longevity support.

Warnings

Not suitable under 18 / during pregnancy / while breastfeeding. Use lowest effective dose. KEEP REFRIGERATED. Disposable pen option is R50 extra.

Storage

Refrigerate at 2-8°C. Do not freeze.

Administration

Subcutaneous injection. Rotate injection sites.

Kit Contents

1 x SS31 100mg Cartridge

Related Products

MOTS-C | NAD+ | SLU-PP-332 | Epitalon